Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test sale cost 21000 AED
Clinical Exome Trio Sequencing Test sale cost 12000 AED Clinical Exome Trio Sequencing Test Cost 15,000 د.إ Original price was: 15,000 د.إ.12,000 د.إCurrent price is: 12,000 د.إ.
Sale!

Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test Cost

Original price was: 28,000 د.إ.Current price is: 21,000 د.إ.

-25%

The Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) Test are advanced genomic profiling assays used in the field of oncology to aid in the personalized treatment of cancer. Conducted at DNA Labs UAE, these tests are designed to identify a wide array of genetic mutations, alterations, and biomarkers across various cancer types.

The Oncomine Comprehensive Panel focuses on analyzing a broad set of genes known to be involved in cancer progression and response to treatments. This helps in pinpointing specific genetic changes in a patient’s tumor, enabling healthcare providers to tailor treatment strategies based on the unique genetic makeup of the cancer.

The Oncomine TMB and MSI Test complements this by measuring the tumor mutation burden and the microsatellite instability in the cancer cells. TMB is an indicator of the number of mutations within the genome of a tumor, which can predict response to immunotherapy. MSI status is a marker for defects in the DNA repair mechanisms, also informing treatment choices, particularly with immunotherapy.

Offered at a cost of 21000 AED, these tests at DNA Labs UAE represent a significant investment in personalized cancer care, allowing for more targeted and potentially effective treatments. By combining the insights from both the comprehensive panel and the TMB and MSI tests, oncologists can make informed decisions to optimize patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test

Are you looking for advanced genetic testing options to diagnose and treat cancer? DNA Labs UAE offers the Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test. In this blog, we will provide detailed information about these tests, including their components, cost, sample condition, report delivery, method, test type, and more.

Test Name: Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test

Components

The test requires paraffin embedded tissue blocks and EDTA Vacutainer (3 ml) as components.

Price

The cost of the Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test is 21000.0 AED.

Sample Condition

The sample condition for this test includes tumor tissue and peripheral blood.

Report Delivery

The report for this test will be delivered within 2-3 weeks.

Method

The Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test utilize next-generation sequencing (NGS) and Sanger sequencing as the method of analysis.

Test Type

This test falls under the category of genetics.

Doctor

It is recommended to consult an oncologist for this test.

Test Department

The test can be performed in the genetics department of DNA Labs UAE.

Pre Test Information

Please note that a doctor’s prescription is required to undergo the Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test. However, the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Details

The Oncomine Comprehensive Panel is a next-generation sequencing panel that analyzes over 500 cancer-related genes for mutations and alterations. It aims to identify potential targets for therapy and provide information on tumor heterogeneity.

The Oncomine Tumor Mutation Burden (TMB) test measures the number of mutations present in a tumor. High TMB has been associated with a better response to immunotherapy in certain cancers.

Microsatellite instability (MSI) is a type of genetic alteration that occurs when the DNA repair system is impaired. MSI is commonly seen in certain types of cancer, such as colorectal cancer, and serves as a biomarker for response to immunotherapy.

By combining the Oncomine Comprehensive Panel with Oncomine TMB and MSI testing, a more comprehensive picture of a patient’s cancer can be obtained, helping guide treatment decisions. This information can be used to identify potential targets for therapy, predict response to immunotherapy, and monitor disease progression.

Don’t wait, consult with an oncologist and get the Oncomine Comprehensive Panel and Oncomine Tumor Mutation Burden and MSI Test done at DNA Labs UAE to gain valuable insights into your cancer and improve your treatment outcomes.

Test Name Oncomine Comprehensive Panel and Oncomine Tumor mutation burden and MSI Test
Components Paraffin embedded tissue blocks + EDTA Vacutainer (3 ml)
Price 21000.0 AED
Sample Condition Tumor tissue + Peripheral Blood
Report Delivery 2-3 weeks
Method NGS + Sanger Sequencing
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Oncomine Comprehensive Panel + Oncomine Tumor mutation burden + MSI can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Oncomine Comprehensive Panel is a next-generation sequencing panel that analyzes over 500 cancer-related genes for mutations and alterations. It is designed to identify potential targets for therapy and provide information on tumor heterogeneity.

Oncomine Tumor mutation burden (TMB) is a measure of the number of mutations present in a tumor. High TMB has been associated with better response to immunotherapy in certain cancers.

Microsatellite instability (MSI) is a type of genetic alteration that occurs when the DNA repair system is impaired. MSI is commonly seen in certain types of cancer, such as colorectal cancer, and is a biomarker for response to immunotherapy.

Combining Oncomine Comprehensive Panel with Oncomine TMB and MSI testing can provide a more comprehensive picture of a patient’s cancer and help guide treatment decisions. This information can be used to identify potential targets for therapy, predict response to immunotherapy, and monitor disease progression.

SKU: TEST-675 Category:

Related products